Michel Janicot

JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

Janine Arts, Peter King, Ann Marin et al. · Clinical Cancer Research · 2009 · 230 citations

Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles

Suzie H. Pun, Frederik Tack, Nathalie C. Bellocq et al. · Cancer Biology & Therapy · 2004 · 199 citations · Full text

Critical Role of the Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Cell Growth

Yonchu Jenkins, Vadim Markovtsov, Wayne Lang et al. · Molecular Biology of the Cell · 2005 · 183 citations · Full text

Chromatin, Tumor Cell Growth, Cell Cycle Checkpoints +15

Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis

Najoua Dendouga, Hui Gao, Dieder Moechars et al. · Molecular and Cellular Biology · 2005 · 148 citations · Full text

Chromatin, Genome Instability, Cell Regulation +15

Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes.

Andrew G. Swick, Michel Janicot, T Cheneval-Kastelic et al. · Proceedings of the National Academy of Sciences · 1992 · 115 citations · Full text

Oocyte, Transcriptional Regulation, Protein Secretion +13